USPTO serial 98858801
JUVENTOLOGY VALTER LONGO FOUNDATION
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SOLANO, CARLITA JAYE
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with JUVENTOLOGY VALTER LONGO FOUNDATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
PLAYA DEL REY, CA, US
PLAYA DEL REY, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ROBERT S. BRODER
ROBERT S. BRODER COLLARD & ROE, P.C.1077 NORTHERN BLVD.Roslyn, NY 11576United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Preparations containing trace elements being minerals for medical purposes; preparations containing trace elements being minerals for human and animal use; chemical preparations for medical purposes, namely, for reaching a healthy weight, improving energy levels, supporting the immune system, managing chronic conditions, and promoting overall quality of life; biochemical preparations for medical use, namely, for reaching a healthy weight, improving energy levels, supporting the immune system, managing chronic conditions, and promoting overall quality of life; antipyretic preparations, adapted for medical purposes; mineral food preparations for medical purposes, namely, freeze-dried food adapted for medical purposes; bacterial preparations for medical purposes; bacteriological preparations for medical purposes; tryptophane preparations, adapted for medical purposes, namely, for reaching a healthy weight, improving energy levels, supporting the immune system managing chronic conditions, and promoting overall quality of life; trichomycin preparations, adapted for medical purposes; paracetamol preparations for oral administration, adapted for medical purposes; enzyme preparations for medical purposes; medicinal healthcare preparations, namely, for reaching a healthy weight, improving energy levels, supporting the immune system, managing chronic conditions, and promoting overall quality of life; medical preparations, namely, for reaching a healthy weight, improving energy levels, supporting the immune system, managing chronic conditions, and promoting overall quality of life; mixed biological preparations for medical purposes, namely, for reaching a healthy weight, improving energy levels, supporting the immune system, managing chronic conditions, and promoting overall quality of life; biological preparations for medical purposes, namely, for reaching a healthy weight, improving energy levels, supporting the immune system, managing chronic conditions, and promoting overall quality of life; amino acid preparations for medical purposes. | ACTIVE | — |
| 042 | Chemical analysis; culturing of cells for others for scientific research purposes; custom design of prototypes; conducting clinical trials for others; biological research; medical research; research in the field of building construction; scientific research; technical writing; scientific laboratory services; development of computer platforms; scientific technological services, namely, medical research services; vaccination services, namely, vaccine research and development. | ACTIVE | — |
| 044 | Nutrition and dietetic consultancy, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; pharmacy advice, namely, providing advice in the field of preparation of prescriptions in pharmacies; health counselling; medical advice for persons with disabilities; remote monitoring of medical data for medical diagnosis and treatment; health centre services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; nursing home services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; continuing care retirement home communities in the nature of nursing home services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; convalescent home services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; medical clinic services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; alternative medicine services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; regenerative medicine services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; hospice services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; telemedicine services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; vaccination services, namely, administering vaccines; health assessment services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; medical services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; hospital services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; mental health therapy services, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes; assistance being consulting services in the field of health and nutrition, for therapeutic purposes, for medical diagnostic purposes and/or for medical prevention purposes. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CREATE CURES INC.
- Other trademarks owned by CREATE CURES INC.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named JUVENTOLOGY VALTER LONGO FOUNDATION
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 29, 2026 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jun 27, 2026 | APET | ASSIGNED TO PETITION STAFF | — |
| Jun 11, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| May 11, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Dec 22, 2025 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 2, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 2, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 26, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 31, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 30, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 30, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 8, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 23, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| May 8, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 8, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 31, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 31, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jan 31, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 31, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 16, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 16, 2025 | ALIE | ASSIGNED TO LIE | — |
| Dec 18, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 18, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 18, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 19, 2024 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Nov 19, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 18, 2024 | NWAP | NEW APPLICATION ENTERED | — |